Cover Image

Liver injury in children: signal analysis of suspected drugs based on the food and drug administration adverse event reporting system

Abstract Background Evidence of drug-induced liver injury is abundant in adults but is lacking in children. Our aim was to identify suspected drug signals associated with pediatric liver injury. Methods Hepatic adverse events (HAEs) among children reported in the Food and Drug Administration Adverse...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yan Liu (Author), Hailong Li (Author), Liang Huang (Author), Chaomin Wan (Author), Huiqing Wang (Author), Xuefeng Jiao (Author), Linan Zeng (Author), Zhijun Jia (Author), Guo Cheng (Author), Lei Zhang (Author), Wei Zhang (Author), Lingli Zhang (Author)
Format:	Book
Published:	BMC, 2023-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
by: Xue-Feng Jiao, et al.
Published: (2023)

Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study
by: Jingying Wu, et al.
Published: (2024)

Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration's adverse event reporting system databases
by: Qiaofang Liang, et al.
Published: (2024)

Safety analysis of pemigatinib leveraging the US Food and Drug administration adverse event reporting system
by: Ying Zhang, et al.
Published: (2023)

Predicting Drugs Suspected of Causing Adverse Drug Reactions Using Graph Features and Attention Mechanisms
by: Jinxiang Yang, et al.
Published: (2024)

Evaluating drug withdrawal syndrome risks through food and drug administration adverse event reporting system: a comprehensive disproportionality analysis
by: Zheng Zhang, et al.
Published: (2024)

Opioid analgesic administration in patients with suspected drug use
by: Maria Clara Giorio Dutra Kreling, et al.

Drug-induced tooth discoloration: An analysis of the US food and drug administration adverse event reporting system
by: Jun Wang, et al.
Published: (2023)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
by: Yankun Liang, et al.
Published: (2023)

Adverse event profiles of drug-induced liver injury caused by antidepressant drugs: a disproportionality analysis
by: Aidou Jiang, et al.
Published: (2024)

Recombinant mycobacterium tuberculosis fusion protein for diagnosis of mycobacterium tuberculosis infection: a short-term economic evaluation
by: Zheng Liu, et al.
Published: (2023)

Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database
by: Zhi-Xuan Zhou, et al.
Published: (2022)

Analysis of Adverse Events and Medical Errors in Long-Term Hormone Treatments for Endometriosis: A Study Based on the US Food and Drug Administration Event Reporting System
by: Zhang Y, et al.
Published: (2022)

Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021
by: Christine Learned, BA, et al.
Published: (2022)

A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases
by: Menglin He, et al.
Published: (2024)

Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis
by: Zhou, Zeyun, et al.
Published: (2020)

Retrospective analysis of adverse events with spironolactone in females reported to the United States Food and Drug Administration
by: Yu Wang, BA, et al.
Published: (2020)

Detection of adverse drug events in e-prescribing and administrative health data: a validation study
by: Bettina Habib, et al.
Published: (2021)

Evaluating cardiac disorders associated with triazole antifungal agents based on the US Food and Drug Administration Adverse Event reporting system database
by: Jinhua Chen, et al.
Published: (2024)

Association of anxiolytic drugs with Torsade de Pointes: a pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System
by: Zahid Ali, et al.
Published: (2024)

The impact of levothyroxine therapy on pregnancy and neonatal outcomes in euthyroid pregnant women with thyroid autoimmunity: A systematic review, meta-analysis and trial sequential analysis
by: Jingjing Chen, et al.
Published: (2023)

Exploring the top 30 drugs associated with drug-induced constipation based on the FDA adverse event reporting system
by: Wenwen Li, et al.
Published: (2024)

Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System
by: Graça M. Dores, et al.
Published: (2019)

Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example
by: Rui Xiong, et al.
Published: (2024)

Suspected adverse drug reactions reported for Brazilian children: cross‐sectional study
by: Elisangela da Costa Lima, et al.
Published: (2019)

Suspected adverse drug reactions reported for Brazilian children: cross-sectional study
by: Elisangela da Costa Lima, et al.
Published: (2019)

Nurses' reporting of suspect adverse drug reactions: a mixed-methods study
by: Alessia De Angelis, et al.
Published: (2015)

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
by: Hayato Katsuno, et al.
Published: (2021)

Clinical drug interactions between linezolid and other antibiotics: For adverse drug event monitoring
by: Ling Shu, et al.
Published: (2024)

Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database
by: Aoi Noda, et al.
Published: (2020)

An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021
by: Xiaotong Li, et al.
Published: (2023)

Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system
by: Wei Wei, et al.
Published: (2023)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021)

Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
by: Xiaoyin Bai, et al.
Published: (2021)

The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration's Adverse Event Reporting System
by: Deemah S. Alsuhaibani, et al.
Published: (2023)

Identifying Crude Drugs in Kampo Medicines Associated with Drug-Induced Liver Injury Using the Japanese Adverse Drug Event Report Database: A Comprehensive Survey
by: Kyosuke Kimura, et al.
Published: (2023)

Adverse event reporting of the IGF-1R monoclonal antibody teprotumumab: a real-world study based on the US food and drug administration adverse event reporting system
by: Jiawei Zhao, et al.
Published: (2024)

Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database
by: Yi Zheng, et al.
Published: (2023)

Variation in adverse drug events of opioids in the United States
by: Edward Y. Liu, et al.
Published: (2023)

Drug-induced fall risk in older patients: A pharmacovigilance study of FDA adverse event reporting system database
by: Shuang Zhou, et al.
Published: (2022)